EOLS
Evolus Inc
Price:  
9.48 
USD
Volume:  
852,343.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS EV/EBITDA

-160.8%
Upside

As of 2025-07-12, the EV/EBITDA ratio of Evolus Inc (EOLS) is -24.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EOLS's latest enterprise value is 665.18 mil USD. EOLS's TTM EBITDA according to its financial statements is -27.32 mil USD. Dividing these 2 quantities gives us the above EOLS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.2x - 10.4x 8.2x
Forward P/E multiples 11.4x - 17.6x 15.0x
Fair Price (5.65) - (5.23) (5.76)
Upside -159.6% - -155.2% -160.8%
9.48 USD
Stock Price
(5.76) USD
Fair Price

EOLS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-10 -24.94
2025-07-09 -24.77
2025-07-08 -23.83
2025-07-07 -23.54
2025-07-03 -23.85
2025-07-02 -23.71
2025-07-01 -23.69
2025-06-30 -23.71
2025-06-27 -23.54
2025-06-26 -23.94
2025-06-25 -23.45
2025-06-24 -24.68
2025-06-23 -24.11
2025-06-20 -23.87
2025-06-18 -23.92
2025-06-17 -23.80
2025-06-16 -25.48
2025-06-13 -25.41
2025-06-12 -26.00
2025-06-11 -26.14
2025-06-10 -25.27
2025-06-09 -24.75
2025-06-06 -25.67
2025-06-05 -24.96
2025-06-04 -25.10
2025-06-03 -25.48
2025-06-02 -25.50
2025-05-30 -23.66
2025-05-29 -24.02
2025-05-28 -23.92
2025-05-27 -25.12
2025-05-23 -24.82
2025-05-22 -24.53
2025-05-21 -24.61
2025-05-20 -25.48
2025-05-19 -25.34
2025-05-16 -24.87
2025-05-15 -25.57
2025-05-14 -25.55
2025-05-13 -25.88
2025-05-12 -25.53
2025-05-09 -25.10
2025-05-08 -25.79
2025-05-07 -29.73
2025-05-06 -29.37
2025-05-05 -30.32
2025-05-02 -30.48
2025-05-01 -29.82
2025-04-30 -28.88
2025-04-29 -29.28